Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$305K Hold
5,641
﹤0.01% 450
2017
Q3
$347K Hold
5,641
﹤0.01% 331
2017
Q2
$343K Hold
5,641
﹤0.01% 354
2017
Q1
$345K Hold
5,641
﹤0.01% 367
2016
Q4
$319K Hold
5,641
﹤0.01% 384
2016
Q3
$338K Hold
5,641
﹤0.01% 379
2016
Q2
$314K Hold
5,641
﹤0.01% 375
2016
Q1
$287K Sell
5,641
-558,912
-99% -$27.4M ﹤0.01% 384
2015
Q4
$28.7M Sell
564,553
-170,377
-23% -$8.59M 0.25% 134
2015
Q3
$34.9M Sell
734,930
-16,072
-2% -$854K 0.3% 114
2015
Q2
$40.8M Sell
751,002
-4,517
-0.6% -$253K 0.3% 115
2015
Q1
$41.4M Sell
755,519
-329,721
-30% -$18.7M 0.31% 122
2014
Q4
$58.8M Sell
1,085,240
-638,976
-37% -$35.6M 0.43% 88
2014
Q3
$97.5M Sell
1,724,216
-91,218
-5% -$5.12M 0.74% 32
2014
Q2
$100M Buy
+1,815,434
New +$99M 0.7% 28

Other funds holding MRK

Virtus Fund Advisers's MRK Position: Q4 2017 in Review

Virtus Fund Advisers held its Merck (MRK) position steady in Q4 2017 at 5,641 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #450.

Virtus Fund Advisers first reported a position in MRK in Q2 2014 and has held it in 15 quarters since. The position peaked at $100M in Q2 2014. 2,008 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • Virtus Fund Advisers held 5,641 shares of Merck worth $305K as of Q4 2017.
  • Virtus Fund Advisers left its Merck share count unchanged in Q4 2017.
  • Merck made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #450 holding.
  • Virtus Fund Advisers first reported a position in Merck in Q2 2014 and has held it in 15 quarters since.
  • Virtus Fund Advisers's Merck position peaked at $100M in Q2 2014.
  • 2,008 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.